Home > Insider Trading > Filing (0001567619-19-021885)

Filing Details

Accession Number:: 0001567619-19-021885
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-19 17:00:54
Reporting Period:: 2019-11-15

Accepted Time:: 2019-11-19 17:00:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1012477	Avadel Pharmaceuticals Plc	AVDL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1410677	J Greg Divis	C/O Avadel Pharmaceuticals Plc Block 10-1 Blanchardstown Corporate Park Dublin L2 15	Chief Executive Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Adss	Acquisiton	2019-11-15	19,000	$5.13	86,100	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Adss	Stock Option (right to buy)	$10.40	2026-12-14	150,000	150,000	Direct
Adss	Stock Option (right to buy)	$8.95	2027-12-12	100,000	100,000	Direct
Adss	Stock Option (right to buy)	$7.06	2028-03-22	50,000	50,000	Direct
Adss	Stock Option (right to buy)	$1.85	2029-03-07	100,000	100,000	Direct
Adss	Stock Option (right to buy)	$1.71	2029-05-30	400,000	400,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2026-12-14	150,000	150,000	Direct
2027-12-12	100,000	100,000	Direct
2028-03-22	50,000	50,000	Direct
2029-03-07	100,000	100,000	Direct
2029-05-30	400,000	400,000	Direct

Footnotes

The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
Includes (a) 22,500 restricted shares granted under the issuer's Omnibus Incentive Compensation Plan on 12/12/2017, of which 15,000 ADSs will vest and be issued on the second anniversary of the grant date and the remaining 7,500 ADSs will vest and be issued on the third anniversary of the grant date (with vesting of these restricted shares subject to the reporting person remaining in continuous service until the applicable anniversary of the date of grant); and (b) 18,000 restricted ADSs granted under the issuer's Omnibus Incentive Compensation Plan on 3/7/2019, of which 12,000 and 6,000 ADSs will vest and be issued to the reporting person on the 2nd anniversary and 3rd anniversary, respectively, of the grant date (with such vesting subject to the reporting person remaining in continuous service until the applicable anniversary).
Options become exercisable as to 37,500 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.
Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/12/2017 grant date.
Options become exercisable as to 12,500 ADSs on each of the first four anniversaries after the 3/22/2018 grant date.
Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 3/7/2019 grant date.
Options become exercisable as to 100,000 ADSs on each of the first four anniversaries after the 5/30/2019 grant date.